These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 28661196)
21. Identification of novel adenosine A(2A) receptor antagonists by virtual screening. Langmead CJ; Andrews SP; Congreve M; Errey JC; Hurrell E; Marshall FH; Mason JS; Richardson CM; Robertson N; Zhukov A; Weir M J Med Chem; 2012 Mar; 55(5):1904-9. PubMed ID: 22250781 [TBL] [Abstract][Full Text] [Related]
22. Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor. Guo D; Xia L; van Veldhoven JP; Hazeu M; Mocking T; Brussee J; Ijzerman AP; Heitman LH ChemMedChem; 2014 Apr; 9(4):752-61. PubMed ID: 24591302 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of 2-benzylidene-1-tetralone derivatives as antagonists of A Legoabe LJ; Van der Walt MM; Terre'Blanche G Chem Biol Drug Des; 2018 Jan; 91(1):234-244. PubMed ID: 28734058 [TBL] [Abstract][Full Text] [Related]
24. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies. Załuski M; Schabikowski J; Schlenk M; Olejarz-Maciej A; Kubas B; Karcz T; Kuder K; Latacz G; Zygmunt M; Synak D; Hinz S; Müller CE; Kieć-Kononowicz K Bioorg Med Chem; 2019 Apr; 27(7):1195-1210. PubMed ID: 30808606 [TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of 2,6-disubstituted-8-amino imidazo[1,2a]pyridines, a promising privileged structure. Boulahjar R; Rincon Arias A; Bolteau R; Renault N; Coevoet M; Barczyk A; Duroux R; Yous S; Melnyk P; Agouridas L Bioorg Med Chem; 2018 Jul; 26(12):3296-3307. PubMed ID: 29753566 [TBL] [Abstract][Full Text] [Related]
26. Novel approaches for targeting the adenosine A2A receptor. Yuan G; Gedeon NG; Jankins TC; Jones GB Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639 [TBL] [Abstract][Full Text] [Related]
27. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: structural investigations at the 5-position to target human A₁ and A(2A) adenosine receptors. Molecular modeling and pharmacological studies. Squarcialupi L; Colotta V; Catarzi D; Varano F; Betti M; Varani K; Vincenzi F; Borea PA; Porta N; Ciancetta A; Moro S Eur J Med Chem; 2014 Sep; 84():614-27. PubMed ID: 25063944 [TBL] [Abstract][Full Text] [Related]
28. A Spinaci A; Lambertucci C; Buccioni M; Dal Ben D; Graiff C; Barbalace MC; Hrelia S; Angeloni C; Tayebati SK; Ubaldi M; Masi A; Klotz KN; Volpini R; Marucci G Molecules; 2022 Apr; 27(8):. PubMed ID: 35458588 [TBL] [Abstract][Full Text] [Related]
29. Discovery of first-in-class multi-target adenosine A Ceni C; Catarzi D; Varano F; Ben DD; Marucci G; Buccioni M; Volpini R; Angeli A; Nocentini A; Gratteri P; Supuran CT; Colotta V Eur J Med Chem; 2020 Sep; 201():112478. PubMed ID: 32659606 [TBL] [Abstract][Full Text] [Related]
30. Adenosine A Yu F; Zhu C; Xie Q; Wang Y J Med Chem; 2020 Nov; 63(21):12196-12212. PubMed ID: 32667814 [TBL] [Abstract][Full Text] [Related]
31. Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists. Zhou G; Aslanian R; Gallo G; Khan T; Kuang R; Purakkattle B; De Ruiz M; Stamford A; Ting P; Wu H; Wang H; Xiao D; Yu T; Zhang Y; Mullins D; Hodgson R Bioorg Med Chem Lett; 2016 Feb; 26(4):1348-54. PubMed ID: 26781932 [TBL] [Abstract][Full Text] [Related]
32. High ligand efficiency quinazoline compounds as novel A Bolteau R; Duroux R; Laversin A; Vreulz B; Shiriaeva A; Stauch B; Han GW; Cherezov V; Renault N; Barczyk A; Ravez S; Coevoet M; Melnyk P; Liberelle M; Yous S Eur J Med Chem; 2022 Nov; 241():114620. PubMed ID: 35933788 [TBL] [Abstract][Full Text] [Related]
33. Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A Masih A; Singh S; Agnihotri AK; Giri S; Shrivastava JK; Pandey N; Bhat HR; Singh UP Neurosci Lett; 2020 Sep; 735():135222. PubMed ID: 32619652 [TBL] [Abstract][Full Text] [Related]
34. Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space. Jörg M; Shonberg J; Mak FS; Miller ND; Yuriev E; Scammells PJ; Capuano B Bioorg Med Chem Lett; 2013 Jun; 23(11):3427-33. PubMed ID: 23602401 [TBL] [Abstract][Full Text] [Related]
35. An Fc-Small Molecule Conjugate for Targeted Inhibition of the Adenosine 2A Receptor. Hsiao PY; Kalin JH; Sun IH; Amin MN; Lo YC; Chiang MJ; Giddens J; Sysa-Shah P; Gabrielson K; Wang LX; Powell JD; Cole PA Chembiochem; 2016 Oct; 17(20):1951-1960. PubMed ID: 27432157 [TBL] [Abstract][Full Text] [Related]
36. Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design. Congreve M; Andrews SP; Doré AS; Hollenstein K; Hurrell E; Langmead CJ; Mason JS; Ng IW; Tehan B; Zhukov A; Weir M; Marshall FH J Med Chem; 2012 Mar; 55(5):1898-903. PubMed ID: 22220592 [TBL] [Abstract][Full Text] [Related]
37. Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment. Shao YM; Ma X; Paira P; Tan A; Herr DR; Lim KL; Ng CH; Venkatesan G; Klotz KN; Federico S; Spalluto G; Cheong SL; Chen YZ; Pastorin G PLoS One; 2018; 13(1):e0188212. PubMed ID: 29304113 [TBL] [Abstract][Full Text] [Related]
38. The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A Falsini M; Squarcialupi L; Catarzi D; Varano F; Betti M; Dal Ben D; Marucci G; Buccioni M; Volpini R; De Vita T; Cavalli A; Colotta V J Med Chem; 2017 Jul; 60(13):5772-5790. PubMed ID: 28590753 [TBL] [Abstract][Full Text] [Related]
39. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists. Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857 [TBL] [Abstract][Full Text] [Related]
40. A New Series of 1,3-Dimethylxanthine Based Adenosine A Rohilla S; Bansal R; Chauhan P; Kachler S; Klotz KN Curr Drug Discov Technol; 2021; 18(5):e26082020185360. PubMed ID: 32860362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]